PP
Pace Pharmaceuticals, Inc.
SEC filingBiotechnology · Cupertino, CA
Amount raised$50Ksold at filing
Total offeringNot stated
Investors in the raise1count reported to the SEC
FiledSep 28, 2026first sale Sep 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas Wang YaoExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.